StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Appaloosa Issues Statement Regarding Allergan's (AGN) Failed Anti-Depression Study, Seeks Independent Chairman
March 7, 2019 10:56 AM
Appaloosa LP today issued a statement in response to Allergan plc’s (NYSE: AGN) (“Allergan”) March 6, 2019 announcement that its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hedge Funds
Management Changes
Next Articles
Allergan (AGN) Reports FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
March 11, 2019 7:32 AM
Appaloosa Issues Statement Regarding Allergan’s Failed Anti-Depression Study
March 7, 2019 10:55 AM
Allergan (AGN) Phase 3 of Rapastinel as Adjunctive Treatment of MDD Did Not Meet Key Endpoints
March 6, 2019 4:19 PM
Allergan Announces Phase 3 Results for Rapastinel as an Adjunctive Treatment of Major Depressive Disorder (MDD)
March 6, 2019 4:17 PM
